You have 2 free disease views remaining today. Register for more view, it is 100% free →
Prader-Willi syndrome
ICD-10 Codes
Related ICD-10:
Description
Prader-Willi Syndrome (PWS) Description
Prader-Willi syndrome (PWS) is a rare genetic condition that affects many parts of the body, leading to physical, mental, and behavioral problems. It is characterized by:
- Weak muscle tone (hypotonia): Infants with PWS have severe low muscle tone, which can lead to feeding difficulties and slow growth.
- Severe obesity: As children grow older, they develop a tremendous appetite, often leading to severe obesity if excessive eating continues.
- Intellectual difficulties: People with PWS may experience learning difficulties, delayed development, and behavioral challenges.
- Metabolic changes: PWS affects the metabolic system, leading to changes in body composition and an increased risk of developing type 2 diabetes.
PWS is a complex genetic condition that can be caused by a deletion or disruption of genes on chromosome 15. It is estimated to occur in approximately one out of every 15,000 births, affecting males and females with equal frequency.
Key Features
- Infancy: Characterized by weak muscle tone (hypotonia), feeding difficulties, poor growth, and delayed development.
- Childhood: Development of a tremendous appetite, leading to severe obesity if excessive eating continues.
- Behavioral challenges: People with PWS may experience behavioral difficulties, including learning problems and intellectual disabilities.
References
- [1] Prader-Willi syndrome is a rare genetic condition that affects many parts of the body. (Source: 2)
- [2] Infants with PWS have severe hypotonia (low muscle tone), feeding difficulties, and slow growth. (Source: 11)
- [3] People with PWS may experience learning difficulties, delayed development, and behavioral challenges. (Source: 12)
Signs and Symptoms
Physical Symptoms
Prader-Willi syndrome (PWS) is characterized by a range of physical symptoms that can vary in severity from person to person. Some common physical symptoms include:
- Weak muscle tone: Infants with PWS may have weak muscle tone, which can cause them to feel floppy and have poor feeding ability [1].
- Poor growth: Children with PWS may experience delayed or restricted growth, leading to short stature [2].
- Almond-shaped eyes: One of the distinctive physical features of PWS is almond-shaped eyes [3].
- Narrowed head at the temples: Some individuals with PWS may have a narrowed head shape at the temples [4].
Behavioral and Developmental Symptoms
In addition to physical symptoms, PWS can also affect an individual's behavior and development. Some common behavioral and developmental symptoms include:
- Feeding difficulties: Infants with PWS may experience feeding difficulties due to weak muscle tone and poor appetite regulation [5].
- Delayed motor function development: Children with PWS may experience delayed or restricted motor function development, which can affect their ability to walk, run, and engage in other physical activities [6].
- Behavioral problems: Individuals with PWS may experience behavioral problems such as temper tantrums, obsessive/compulsive behavior, and skin picking [7].
Other Symptoms
Other symptoms associated with PWS include:
- Gastrointestinal issues: Some individuals with PWS may experience gastrointestinal issues such as vomiting and stomach pain due to gastric rupture [8].
- Overeating and weight gain: Individuals with PWS may experience an excessive appetite and overeating, which can lead to dangerous weight gain if not managed properly [9].
It's essential to note that the severity and range of symptoms associated with PWS can vary significantly from person to person. Regular medical check-ups and early intervention can help manage symptoms and improve quality of life.
References:
[1] Context 1 [2] Context 4 [3] Context 11 [4] Context 9 [5] Context 10 [6] Context 6 [7] Context 3 [8] Context 4 [9] Context 5
Diagnostic Tests
Diagnosing Prader-Willi Syndrome: A Comprehensive Overview
Prader-Willi syndrome (PWS) is a rare genetic disorder that affects various aspects of an individual's life, including physical and cognitive development. Accurate diagnosis is crucial for effective management and treatment of the condition.
Diagnostic Methods
Several diagnostic tests are employed to confirm PWS:
- Methylation analysis: This is the preferred method of testing, which detects >99% of cases, including all major genetic subtypes of PWS (deletion, uniparental disomy, and imprinting defects) [2][3].
- Chromosomal or microarray analysis: These tests are used to identify chromosomal abnormalities associated with PWS [4].
- DNA testing: DNA methylation studies followed by confirmation with FISH for any positive result yields a significant cost savings compared with other approaches [7].
- Multiplex ligation probe amplification (MLPA): This test is used to identify abnormal methylation of the PWS/AS region of chromosome 15 [8].
Clinical Diagnostic Criteria
Formal diagnostic criteria for recognizing PWS depend on the age of the individual, specifically:
- In newborns, physical symptoms such as inability to suck or feed and a "floppy" body with weak muscle tone may prompt genetic testing for PWS [3].
- For older individuals, clinical signs and symptoms such as short stature, intellectual disability, and behavioral problems are used to raise diagnostic suspicion of PWS [6].
Importance of DNA Methylation Testing
DNA methylation testing is essential in diagnosing PWS, as it can identify virtually all persons affected with the condition [9]. This test is widely available in many genetics laboratories.
References
[1] Foundation for Prader-Willi Research. How is Prader-Willi Syndrome Diagnosed?
[2] Smith A. Molecular genetic tests for Prader-Willi syndrome: a review. 2017; Cited by 46
[3] Monaghan KG. DNA methylation studies followed by confirmation with FISH for any positive result yields a significant cost savings compared with other approaches. 2002; Cited by 17
[4] Wattendorf DJ. Methylation analysis will identify virtually all persons affected with PWS. Many genetics laboratories offer both of these tests and can... 2005; Cited by 97
[5] Quest Diagnostics Incorporated. Quest is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies.
[6] Driscoll DJ, Miller JL, Cassidy SB. Prader-Willi Syndrome. [Updated 2023]
Note: The references provided are a selection of relevant sources from the search results.
Treatment
Treatment Options for Prader-Willi Syndrome
Prader-Willi syndrome (PWS) is a rare genetic disorder that affects various aspects of an individual's life, including growth and development, behavior, and physical characteristics. While there is no cure for PWS, various treatment options are available to manage its symptoms.
Hormone Replacement Therapy
One of the primary treatments for PWS is hormone replacement therapy (HRT). This involves administering human growth hormone (HGH) or somatropin to help improve muscle tone and promote growth in children with PWS. According to [1], HGH treatment can be beneficial for infants and children with PWS, making muscle tone better and helping them grow.
A type of HGH called somatropin is commonly used to treat children with PWS. Somatropin is given by daily injection, and most children tolerate it well [2].
Psychotropic Medications
In addition to HRT, psychotropic medications are often prescribed to manage behavioral symptoms associated with PWS. Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), is commonly used to reduce anxiety, stabilize behavior, or treat depression in individuals with PWS [3]. SSRIs like fluoxetine have been reported to work well for anxiety in PWS patients [4].
Behavioral Interventions
Behavioral interventions are also an essential aspect of treatment in PWS. These should be tried before psychotropic medications are used and in combination with all other treatments [5].
Other Treatments
Several new therapies, including medications, devices, and others, are currently being developed to treat PWS. The development phases range from very early discovery and preclinical studies to clinical trials [6]. For example, diazoxide choline (DCCR) has been granted Breakthrough Therapy Designation by the FDA for the treatment of PWS [7].
Quality of Life Improvement
Research has shown that growth hormone therapy can improve health-related quality of life (HRQOL) in children with Prader-Willi syndrome [8]. A study by Bakker et al indicated that growth hormone therapy improves HRQOL in children with PWS, making it a valuable treatment option.
Common Treatments
Common treatments for PWS include growth hormone (GH) therapy, treatment of hypogonadism with either testosterone or human chorionic gonadotropin, and behavioral interventions [9].
References:
[1] Context 1 [2] Context 2 [3] Context 7 [4] Context 7 [5] Context 8 [6] Context 4 [7] Context 5 [8] Context 9 [9] Context 11
Recommended Medications
- Somatropin
- Hormone Replacement Therapy
- Growth Hormone (GH) therapy
- Diazoxide Choline (DCCR)
- Human chorionic gonadotropin
- fluoxetine
- Fluoxetine
- testosterone
- Testosterone
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnosis of Prader-Willi Syndrome
Prader-Willi syndrome (PWS) is a complex genetic disorder that can be challenging to diagnose, especially in older individuals or those with atypical presentations. The differential diagnosis of PWS includes several conditions that may share similar characteristics, such as obesity, hypotonia, and developmental delays.
Conditions to Consider:
- Bardet-Biedl syndrome: A rare genetic disorder characterized by obesity, intellectual disability, and polydactyly (extra fingers or toes).
- Alström syndrome: A rare genetic disorder that affects the eyes, ears, heart, and other organs, often presenting with obesity and developmental delays.
- Temple syndrome (TS14): An imprinting syndrome that shares many features with PWS, including hypotonia, feeding difficulties, and intellectual disability.
- 6q16 deletion syndrome: A rare genetic disorder characterized by growth retardation, intellectual disability, and distinctive facial features.
- Congenital myopathies: A group of muscle disorders that can present with hypotonia and weakness in infancy or early childhood.
Key Features to Consider:
- Hypotonia: Severe infantile hypotonia is a common feature of PWS, but it may also be present in other conditions such as congenital myopathies.
- Obesity: While obesity is a hallmark of PWS, it can also be present in other syndromes such as Bardet-Biedl syndrome and Alström syndrome.
- Developmental delays: Intellectual disability and developmental delays are common features of PWS, but they may also be present in other conditions such as Temple syndrome.
Diagnostic Considerations:
- Genetic testing: Genetic testing can help confirm the diagnosis of PWS or rule out other genetic syndromes.
- Clinical evaluation: A thorough clinical evaluation by a multidisciplinary team is essential to diagnose and manage PWS.
- Imaging studies: Imaging studies such as MRI or CT scans may be necessary to rule out other conditions that may present with similar features.
References:
- [1] Prader-Willi syndrome (PWS) is a complex neurodevelopmental genetic disorder affecting various aspects of development. (Source: [10])
- [2] The differential diagnosis of PWS includes several conditions that share similar characteristics, such as obesity and hypotonia. (Source: [11])
- [3] Genetic testing can help confirm the diagnosis of PWS or rule out other genetic syndromes. (Source: [13])
Additional Differential Diagnoses
- Birk-Barel syndrome
- Borjeson-Forssman-Lehmann syndrome
- Armfield syndrome
- obsolete Jensen syndrome
- autosomal dominant intellectual developmental disorder
- mitochondrial complex V (ATP synthase) deficiency nuclear type 4
- chromosome 15q24 deletion syndrome
- chromosome 17q23.1-q23.2 deletion syndrome
- chromosome 18q deletion syndrome
- chromosome 1p36 deletion syndrome
- chromosome 1q41-q42 deletion syndrome
- chromosome 2p12-p11.2 deletion syndrome
- chromosome 2q31.2 deletion syndrome
- chromosome 4q21 deletion syndrome
- chromosome 6q24-q25 deletion syndrome
- chromosome 19p13.13 deletion syndrome
- chromosomal duplication syndrome
- chromosome 1q21.1 duplication syndrome
- chromosome 3q29 microduplication syndrome
- Mowat-Wilson syndrome
- Pitt-Hopkins syndrome
- chromosome 9p deletion syndrome
- Smith-Magenis syndrome
- syndromic X-linked intellectual disability Claes-Jensen type
- neurodevelopmental disorder with hypotonia, stereotypic hand movements, and impaired language
- obsolete Koolen-De Vries syndrome
- congenital disorder of glycosylation type IIi
- Luo-Schoch-Yamamoto syndrome
- multiple congenital anomalies-hypotonia-seizures syndrome 1
- mosaic variegated aneuploidy syndrome 2
- Phelan-McDermid syndrome
- multiple congenital anomalies-hypotonia-seizures syndrome
- Galloway-Mowat syndrome
- 7q11.23 duplication syndrome
- craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development syndrome 1
- neurodevelopmental disorder with poor growth, spastic tetraplegia, and hearing loss
- neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures
- congenital myopathy 9A
- congenital myopathy 17
- congenital myopathy 22B
- hypogonadotropic hypogonadism 19 with or without anosmia
- Bardet-Biedl syndrome 2
- Bardet-Biedl syndrome 3
- Bardet-Biedl syndrome 4
- Bardet-Biedl syndrome 5
- Bardet-Biedl syndrome 7
- Bardet-Biedl syndrome 9
- Bardet-Biedl syndrome 14
- Bardet-Biedl syndrome 15
- Bardet-Biedl syndrome 17
- Bardet-Biedl syndrome 19
- congenital myasthenic syndrome 21
- nemaline myopathy 9
- Joubert syndrome 26
- centronuclear myopathy 6 with fiber-type disproportion
- intellectual developmental disorder with short stature and behavioral abnormalities
- chromosome 2q37 deletion syndrome
- Temple syndrome
- Mulchandani-Bhoj-Conlin syndrome
- Schaaf-Yang syndrome
- Shukla-Vernon syndrome
- Bardet-Biedl syndrome
- nemaline myopathy
- fragile X syndrome
- acanthosis nigricans
- Angelman syndrome
- spastic tetraplegia, thin corpus callosum, and progressive microcephaly
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- rdf-schema#comment
- OMIM mapping confirmed by DO. [SN].
- oboInOwl#id
- DOID:11983
- core#notation
- DOID:11983
- oboInOwl#hasDbXref
- UMLS_CUI:C0032897
- IAO_0000115
- A chromosomal disease that is characterized by weak muscle tone, feeding difficulties, poor growth, and delayed development. Beginning in childhood, affected individuals develop an insatiable appetite, which leads to chronic overeating and obesity.
- oboInOwl#hasExactSynonym
- Prader Willi syndrome
- rdf-schema#label
- Prader-Willi syndrome
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#NCIthesaurus
- RO_0004019
- http://purl.obolibrary.org/obo/SYMP_0000462
- rdf-schema#subClassOf
- t398869
- relatedICD
- http://example.org/icd10/Q87.11
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_7848
- owl#annotatedSource
- t398408
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.